Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure.
Previous investigations have suggested that beta-adrenoceptor-mediated responses were decreased in uremia. To evaluate this phenomenon further, beta 2-receptor density in mononuclear cells, plasma catecholamines and plasma parathyroid hormone were studied in two groups of normotensive patients: group U, twenty-five chronic uremic patients with end-stage renal failure; group C, twenty-eight control subjects. Each group was divided into three age and sex-matched subgroups. Beta 2-receptor density was determined using (-)125 iodocyanopindolol. Despite a significant increase in plasma epinephrine in the group of uremic patients, there was a significant increase in beta 2-adrenoceptor density. On the other hand the uremic state did not influence (-)125 iodocyanopindolol binding affinity and plasma norepinephrine. Parathyroid hormone, as expected, was significantly elevated in all the uremic subgroups. It can be concluded that the uremic state is associated with an unexpected upregulation of beta 2-receptor density in mononuclear cells. The role of an endogenous beta-blocking substance is suggested.
D000328:Adult; D000367:Age Factors; D000368:Aged; D002395:Catecholamines / Q000097:blood; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D020120:Iodocyanopindolol; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008214:Lymphocytes / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000032:analysis*; D010281:Parathyroid Hormone / Q000097:blood; D010869:Pindolol / Q000031:analogs & derivatives / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000032:analysis*
D002395:Catecholamines; D010281:Parathyroid Hormone; D011943:Receptors, Adrenergic, beta; D020120:Iodocyanopindolol; D010869:Pindolol